Soluble Low-density Lipoprotein Receptor-related Protein 1 in Juvenile Idiopathic Arthritis

2020 ◽  
pp. jrheum.200391
Author(s):  
Elham Rezaei ◽  
Marianna M. Newkirk ◽  
Zhenhong Li ◽  
John R. Gordon ◽  
Kiem G. Oen ◽  
...  

Objective This study aimed to expand knowledge about soluble low-density lipoprotein receptor-related protein 1(sLRP1) in juvenile idiopathic arthritis (JIA) by determining associations of sLRP1 levels in non-systemic JIA patients with clinical and inflammatory biomarker indicators of disease activity. Methods Plasma sLRP1 and 46 inflammation-related biomarkers were measured at enrollment and six months later in a cohort of 96 newly diagnosed Canadian non-systemic JIA patients. Relationships between sLRP1 levels and indicators of disease activity and biomarker levels were analyzed at both visits. Results At enrollment, sLRP1 levels correlated negatively with age and active joint counts. Children showed significantly higher levels of sLRP1 than adolescents (mean ranks: 60.7 and 47.8, respectively; p=0.032). Participants with four or fewer active joints compared to those with five or more active joints, had significantly higher sLRP1 levels (mean ranks: 60.6, and 44.7, respectively; p=0.007). At enrollment, considering the entire cohort, sLRP1 correlated negatively with the number of active joints (r=-0.235; p=0.017). In the entire cohort, sLRP1 levels at enrollment and six months after correlated with 13 and six pro-and anti-inflammatory biomarkers, respectively. In JIA categories, sLRP1 correlations with inflammatory markers were significant in rheumatoid factor negative polyarticular JIA, oligoarticular JIA, enthesitis related arthritis, and psoriatic arthritis at enrollment. Higher sLRP1 levels at enrollment increased the likelihood of absence of active joints 6 months later. Conclusion Plasma sLRP1 levels correlate with clinical and biomarker indicators of short-term improvement in JIA disease activity supporting sLRP1 as an upstream biomarker of potential utility for assessing JIA disease activity and outcome prediction.

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Jie Qu ◽  
Sarah Fourman ◽  
Maureen Fitzgerald ◽  
Min Liu ◽  
Supna Nair ◽  
...  

AbstractApolipoprotein A4 (APOA4) is one of the most abundant and versatile apolipoproteins facilitating lipid transport and metabolism. APOA4 is synthesized in the small intestine, packaged onto chylomicrons, secreted into intestinal lymph and transported via circulation to several tissues, including adipose. Since its discovery nearly 4 decades ago, to date, only platelet integrin αIIbβ3 has been identified as APOA4 receptor in the plasma. Using co-immunoprecipitation coupled with mass spectrometry, we probed the APOA4 interactome in mouse gonadal fat tissue, where ApoA4 gene is not transcribed but APOA4 protein is abundant. We demonstrate that lipoprotein receptor-related protein 1 (LRP1) is the cognate receptor for APOA4 in adipose tissue. LRP1 colocalized with APOA4 in adipocytes; it interacted with APOA4 under fasting condition and their interaction was enhanced during lipid feeding concomitant with increased APOA4 levels in plasma. In 3T3-L1 mature adipocytes, APOA4 promoted glucose uptake both in absence and presence of insulin in a dose-dependent manner. Knockdown of LRP1 abrogated APOA4-induced glucose uptake as well as activation of phosphatidylinositol 3 kinase (PI3K)-mediated protein kinase B (AKT). Taken together, we identified LRP1 as a novel receptor for APOA4 in promoting glucose uptake. Considering both APOA4 and LRP1 are multifunctional players in lipid and glucose metabolism, our finding opens up a door to better understand the molecular mechanisms along APOA4-LRP1 axis, whose dysregulation leads to obesity, cardiovascular disease, and diabetes.


Sign in / Sign up

Export Citation Format

Share Document